Adaptive Biotechnologies Corp. (ADPT)
28.35
+0.98
(+3.58%)
USD |
NASDAQ |
Oct 02, 16:00
28.34
-0.02
(-0.05%)
Pre-Market: 20:00
Adaptive Biotechnologies Profit Margin (Quarterly) : -55.82% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.82% |
| March 31, 2026 | -28.24% |
| December 31, 2025 | -18.94% |
| September 30, 2025 | 10.16% |
| June 30, 2025 | -43.47% |
| March 31, 2025 | -56.88% |
| December 31, 2024 | -71.04% |
| September 30, 2024 | -69.12% |
| June 30, 2024 | -107.1% |
| March 31, 2024 | -113.5% |
| December 31, 2023 | -151.7% |
| September 30, 2023 | -132.7% |
| June 30, 2023 | -97.72% |
| March 31, 2023 | -153.3% |
| December 31, 2022 | -72.77% |
| September 30, 2022 | -94.75% |
| Date | Value |
|---|---|
| June 30, 2022 | -119.3% |
| March 31, 2022 | -162.6% |
| December 31, 2021 | -161.8% |
| September 30, 2021 | -141.9% |
| June 30, 2021 | -128.0% |
| March 31, 2021 | -105.7% |
| December 31, 2020 | -147.7% |
| September 30, 2020 | -139.6% |
| June 30, 2020 | -159.8% |
| March 31, 2020 | -150.2% |
| December 31, 2019 | -85.14% |
| September 30, 2019 | -53.53% |
| June 30, 2019 | -73.94% |
| March 31, 2019 | -147.2% |
| June 30, 2018 | -108.0% |
| March 31, 2018 | -127.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Personalis, Inc. | -141.7% |
| 10X Genomics, Inc. | -11.87% |
| Alamar Biosciences, Inc. (California) | -44.85% |
| Champions Oncology, Inc. | -2.80% |
| Medpace Holdings, Inc. | 17.16% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.53% |
| Return on Assets | -10.33% |
| Return on Invested Capital | -14.26% |
| Gross Profit Margin (Quarterly) | 70.15% |
| Operating Margin (Quarterly) | -21.93% |
| Return on Net Operating Assets | -25.22% |